Enliven Therapeutics (ELVN) Q4 2021 Earnings

15MarExpected
Q1 2021
Q2 2021
Q3 2021
Q4 2021
-2.96
-2.22
-1.49
-0.75

Details

Expected EPS
-0.7511
Actual EPS
-2.12
Surprise EPS
-1.37
Surprise Percent
+182.25%

Description

Enliven Therapeutics (ELVN) has reported earnings of -2.12 per share for Q4 2021.

0 Comments

Share your thoughts